Advertisement

Payer Interest in Oncology Clinical Pathways Continues

First implemented more than 10 years ago, oncology clinical pathways (OCPs) continue to be a method that payers use or are interested...

Minority of mNSCLC Patients Got Oral Therapies During Initial Availability

Despite the approval of certain oral therapies for non-small cell lung cancer (NSCLC), the majority of patients with metastatic disease did not...

Driving Value-based Success Among Pharmacists in Health Systems and Health Plans

In 1977, health care spending as a share of gross domestic product (GDP) was a mere 8.4%, but absolute costs and share...

AMCP Keeps Tabs on Legislative and Regulatory Developments

2021 began with a new administration in the White House, a new majority party in Congress, and a continuing global pandemic. Despite...

Collaboration: The Key to Fighting COVID-19 and Improving Patient Care Overall

In an opening session presentation at AMCP 2021, Dr. Freda Lewis-Hall, MD, a former chief medical officer at Pfizer, Inc., declared that...
Advertisement